INVESTMENT OBJECTIVE (unaudied)
The Fund’s investment objective is to achieve a high total investment return, consistent with reasonable risk.
Manager Discussion of Fund Performance
Below, Value Line Strategic Asset Management Trust portfolio managers Stephen E. Grant, Jeffrey D. Geffen and Liane Rosenberg discuss the Fund’s performance and positioning for the six months ended June 30, 2019.
How did the Fund perform during the semi-annual period?
The Fund generated a total return of 22.21% during the six months ended June 30, 2019. This compares to the 13.64% return of the Fund’s blended benchmark, composed 60% of the S&P 500® Index and 40% of the Bloomberg Barclays US Aggregate Bond Index (the Bloomberg Barclays Index), during the same semi-annual period.
What key factors were responsible for the Fund’s performance during the six-month reporting period?
The Fund significantly outperformed its blended benchmark during the six-month reporting period. The equity portion of the Fund substantially outperformed the 18.54% return of the S&P 500® Index, and the fixed income portion of the Fund significantly outperformed the 6.11% return of the Bloomberg Barclays Index during the semi-annual period. Further, during the semi-annual period, growth-oriented stocks outpaced value-oriented stocks by a wide margin. This style preference by investors at large proved a plus for the equity portion of the Fund, which emphasizes growth over value.
Asset allocation contributed positively as well. The Fund was overweighted in stocks and underweighted in fixed income during a semi-annual period when the double-digit positive absolute return of the S&P 500® Index outpaced the still solid single-digit positive absolute return of the Bloomberg Barclays Index.
Which equity market sectors most significantly affected Fund performance?
The equity portion of the Fund benefited most from stock selection overall. Sector allocation decisions as a whole also contributed positively, albeit more modestly, during the reporting period.
The equity portion of the Fund benefited most from effective stock selection in the health care and industrials sectors. Stock selection in the real estate and materials sectors further boosted the equity portion of the Fund’s relative results. Only partially offsetting these positive contributors was weak stock selection in consumer discretionary, which detracted.
What were some of the Fund’s best-performing individual stocks?
Among the individual stocks that contributed most to the equity portion of the Fund’s results were Heico, which manufactures aerospace and defense products; Mettler-Toledo International, which manufactures weighing instruments for use in laboratory, industrial and food retailing applications; and Idexx Laboratories, which provides diagnostic, detection and information systems for veterinary, food and water testing applications. Each of these stocks enjoyed robust double-digit gains during the semi-annual period driven by better than expected operating performance.
Which stocks detracted significantly from the Fund’s performance during the semi-annual period?
During the semi-annual period, the equity portion of the Fund was hurt most by not owning software behemoth Microsoft and social media giant Facebook, which posted strong gains during the semi-annual period. However, currently, the equity portion of the Fund’s strategy does not typically invest in giant, mega-cap companies. Also, the equity portion of the Fund’s position in Rollins, which provides pest control services, detracted from the Fund’s results. Rollins’ shares declined during the semi-annual period primarily attributable to weaker than expected operating performance.
Did the equity portion of the Fund make any significant purchases or sales?
During the semi-annual period, the only new holding established in the Fund was that of animal health technology and services provider Covetrus, a position initiated when it was spun off from the Fund’s holding of health care products and services distributor Henry Schein.